SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028982
Filing Date
2018-11-13
Accepted
2018-11-09 17:45:33
Documents
49
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nvus-10q_20180930.htm 10-Q 1186399
2 EX-31.1 nvus-ex311_11.htm EX-31.1 11356
3 EX-31.2 nvus-ex312_9.htm EX-31.2 11497
4 EX-32.1 nvus-ex321_7.htm EX-32.1 7500
5 EX-32.2 nvus-ex322_12.htm EX-32.2 7880
  Complete submission text file 0001564590-18-028982.txt   3927497

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nvus-20180930.xml EX-101.INS 659328
7 XBRL TAXONOMY EXTENSION SCHEMA nvus-20180930.xsd EX-101.SCH 39032
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvus-20180930_cal.xml EX-101.CAL 38548
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvus-20180930_def.xml EX-101.DEF 91064
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvus-20180930_lab.xml EX-101.LAB 257194
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvus-20180930_pre.xml EX-101.PRE 192030
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36620 | Film No.: 181174272
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1